2013
DOI: 10.4161/hv.25788
|View full text |Cite
|
Sign up to set email alerts
|

Biophysical and formulation studies of theSchistosoma mansoniTSP-2 extracellular domain recombinant protein, a lead vaccine candidate antigen for intestinal schistosomiasis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
6
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
6
4

Relationship

3
7

Authors

Journals

citations
Cited by 19 publications
(7 citation statements)
references
References 39 publications
1
6
0
Order By: Relevance
“…However, compared to each adjuvant alone control, only As37 formulated with AddaVax induced significant protection (48.7%, P<0.01). Alhydrogel is an alum-based adjuvant mainly stimulating a Th2-type response [48,49], confirmed by the high ratio of IgG1/IgG2a (380:1) and high levels of IL-4, IL-5, and IL-10 in this study. MPLA (Monophosphoryl Lipid A) is a potent activator of TLR4 that stimulates a strong Th1 response or a combined Th1/Th2 response [50], confirmed by high levels of INF-γ and a low IgG1/IgG2a ratio (20:1).…”
Section: Discussionsupporting
confidence: 72%
“…However, compared to each adjuvant alone control, only As37 formulated with AddaVax induced significant protection (48.7%, P<0.01). Alhydrogel is an alum-based adjuvant mainly stimulating a Th2-type response [48,49], confirmed by the high ratio of IgG1/IgG2a (380:1) and high levels of IL-4, IL-5, and IL-10 in this study. MPLA (Monophosphoryl Lipid A) is a potent activator of TLR4 that stimulates a strong Th1 response or a combined Th1/Th2 response [50], confirmed by high levels of INF-γ and a low IgG1/IgG2a ratio (20:1).…”
Section: Discussionsupporting
confidence: 72%
“…To further interpret the protective immunological mechanism underlying the protection induced by As16, three other adjuvants (Alhydrogel, MPLA and AddaVax) were formulated with rAs16. Alhydrogel, an alum-based adjuvant approved by the FDA for use in humans, is known to stimulate a Th2-type response [ 50 , 51 ]. MPLA (Monophosphoryl Lipid A) is a potent activator of TLR4 that boosts a combined Th1/Th2 response [ 52 ].…”
Section: Discussionmentioning
confidence: 99%
“…In both Bm- FAR-1 and Bm- FAR-2 immunization, Montanide-720 adjuvant induced better protection than did alum. Montanide-720 is a water-in-oil emulsion preparation that induces strong and broad Th1- and Th2-associated humoral and cellular immune responses [ 46 , 47 ], while alum is known to stimulate a Th2-type humoral and cellular response [ 48 ]. The adjuvants used here may therefore elicit different immunoglobulin isotype dominances (e.g.…”
Section: Discussionmentioning
confidence: 99%